News About: Pharm. Industry
Ipsen Korea appointed Min-young Kim as a new CEOIpsen Korea appointed Min-young Kim as a CEO from the 15th of May.
After graduating College of Pharmacy, Seoul National University, CEO Min-young Kim passed though Bukwang Phar...
|
15 domestic pharmaceutical companies which have challenged to the use patent of Crestor received the ‘declaration of inadmissibility’
Domestic pharmaceutical companies which have challenged to the use patent of ‘Crestor’ received the declaration of inadmissibility.
When it comes to the nullity suit filed by 15 domestic pharmaceutical companies agai...
Pfizer won the ‘Prevenar’ patent nullity suit against SK ChemicalsPfizer won the Prevenar 13 patent suit proposed by SK Chemicals in 2013.
According to industry concerned on the 12th, the Intellectual Property Tribunal took the side of Pfizer...
|
Boryung Pharmaceutical is about to expand to the Asian market with ‘Kanarb’It is known that the Boryung Pharmaceutical’s self-developed new hypertension treatment, ‘Kanarb,’ will soon be advanced to the Asian market.
According to the industry concerne...
|
The pharmaceutical association will get on inspection of distribution companies causing irregularities
The Korea Pharmaceutical Manufacturers Association (KPMA) decided to review a measure to inspect the actual condition of pharmaceutical distribution companies disturbing the pharmaceutical distribution order. In order...
BMS CEO will be replaced while CEO Eun-young Kim is appointed as the new CEO of Allergan Korea
It has been 9 months. BMS Korea CEO is changed again.
According to the industry concerned on the 11th, CEO Eun-young Kim of its Korean branch left the company. It has been approximately 9 months since the appointment...
The pharmaceutical industry raised concerns of sales due to MERS
Due to MERS(Middle East Respiratory Syndrome), pharmaceutical companies have raised concerns about sales. Although the industry had shared an atmosphere not to make a huge deal out of the outbreak of MERS until a cert...
President of the Korean Medical Association asked “Support for medical institutions,” and Prime Minister replied “I’ll take an immediate action”
Acting Prime Minister Kyung-hwan Choi visited inspected Konyang Univ. Hospital, managing and treating MERS-diagnosed patients, to inspect its responsive posture and delivered gratitude to medical personnel and institu...
Pharmaceutical companies working hard to take an advantage of MERS
Pharmaceutical companies, which attempt to take an advantage of MERS, are working hard. It is observed that pharmaceutical companies that owns products having effectiveness towards MERS have silently expanded promotio...
While targeted treatments emerge continuously, the insurance benefit causes difficulties in the market
While many pharmaceutical companies had focused on the development of chronic disease treatments, such as hypertension and diabetes, in early-2000s, the latest new drug trend is the R&D of targeted agents and rare dis...
